Indication: COVID-19 (CMDU only)
RAG rating: Red
Document type: NICE technology appraisal
Place: Hertfordshire and West Essex ICB
Output type: Pharmacy / Prescribing

Molnupiravir

Molnupiravir (Lagevrio) is recommended for restricted use as an option for treating mild to moderate COVID‑19 in eligible adult groups in line with NICE TA1056.

Eligible patients reporting a positive test should be advised to call 111 urgently for an assessment for COVID-19 treatment. They will determine which treatment, if any, is suitable, and make any necessary arrangements for prescribing oral treatments for dispensing at a community pharmacy, or for a hospital referral if intravenous treatment is needed.

Information for patients is available at COVID-19 medicines (CMDU) - Herts and West Essex ICS

Back